Primary Site >> Biliary tract Cancer

Gene >> ERBB2

Journal: Am J Clin Pathol. 1992 May;97(5 Suppl 1):S53-61.
Title: Immunoreactivity for c-erbB-2 oncopeptide in benign and malignant diseases of the liver.
Author: Brunt, E M|Swanson, P E
PMID: 1374219
Journal: J Pathol. 1996 Feb;178(2):140-5.
Title: Overexpression of different members of the type 1 growth factor receptor family and their association with cell proliferation in periampullary carcinoma.
Author: Vaidya, P|Kawarada, Y|Higashiguchi, T|Yoshida, T|Sakakura, T|Yatani, R
PMID: 8683379
Journal: J Dermatol. 1996 Mar;23(3):191-5.
Title: Hereditary onset of multiple seborrheic keratoses: a variant of Leser Trelat sign?
Author: Yamamoto, T|Yokoyama, A
PMID: 8935630
Journal: Am J Pathol. 1997 Dec;151(6):1685-94.
Title: NEU overexpression in the furan rat model of cholangiocarcinogenesis compared with biliary ductal cell hyperplasia.
Author: Sirica, A E|Radaeva, S|Caran, N
PMID: 9403719
Journal: Hepatology. 1998 Apr;27(4):974-82.
Title: Expression of E-cadherin, alpha-catenin, beta-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study.
Author: Ashida, K|Terada, T|Kitamura, Y|Kaibara, N
PMID: 9537436
Journal: Hepatology. 1999 May;29(5):1453-62.
Title: Overexpression of C-NEU and C-MET during rat liver cholangiocarcinogenesis: A link between biliary intestinal metaplasia and mucin-producing cholangiocarcinoma.
Author: Radaeva, S|Ferreira-Gonzalez, A|Sirica, A E
PMID: 10216129
Journal: Pathol Res Pract. 2001;197(2):95-100.
Title: Expression and clinical significance of the erbB family in intrahepatic cholangiocellular carcinoma.
Author: Ito, Y|Takeda, T|Sasaki, Y|Sakon, M|Yamada, T|Ishiguro, S|Imaoka, S|Tsujimoto, M|Higashiyama, S|Monden, M|Matsuura, N
PMID: 11261824
Journal: J Gastroenterol Hepatol. 2001 Apr;16(4):363-72.
Title: Biliary cancer growth factor pathways, cyclo-oxygenase-2 and potential therapeutic strategies.
Author: Sirica, A E|Lai, G H|Zhang, Z
PMID: 11357901
Journal: Hepatogastroenterology. 2001 Sep-Oct;48(41):1266-70.
Title: Proliferating cell nuclear antigen, p53, and c-erbB-2 expression in relation to clinicopathological variables and prognosis in cancer of the ampulla of Vater.
Author: Ajiki, T|Kamigaki, T|Hasegawa, Y|Fujino, Y|Suzuki, Y|Takeyama, Y|Ku, Y|Kuroda, Y
PMID: 11677943
Journal: Histopathology. 2002 Mar;40(3):269-78.
Title: c-erbB-2 and c-Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma.
Author: Aishima, S-I|Taguchi, K-I|Sugimachi, K|Shimada, M|Sugimachi, K|Tsuneyoshi, M
PMID: 11895493
Journal: J Hepatol. 2002 Jun;36(6):780-5.
Title: Gene amplification and mRNA and protein overexpression of c-erbB-2 (HER-2/neu) in human intrahepatic cholangiocarcinoma as detected by fluorescence in situ hybridization, in situ hybridization, and immunohistochemistry.
Author: Ukita, Yoko|Kato, Masako|Terada, Tadashi
PMID: 12044528
Journal: Dig Liver Dis. 2003 May;35(5):332-8.
Title: Investigation of ErbB1 and ErbB2 expression for therapeutic targeting in primary liver tumours.
Author: Altimari, A|Fiorentino, M|Gabusi, E|Gruppioni, E|Corti, B|D'Errico, A|Grigioni, W F
PMID: 12846405
Journal: Hepatology. 2004 Jan;39(1):220-9.
Title: MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type.
Author: Shibahara, Hiroaki|Tamada, Shugo|Higashi, Michiyo|Goto, Masamichi|Batra, Surinder K|Hollingsworth, Michael A|Imai, Kohzoh|Yonezawa, Suguru
PMID: 14752841
Journal: Oncol Rep. 2004 Apr;11(4):815-9.
Title: Gallbladder cancers rarely overexpress HER-2/neu, demonstrated by Hercep test.
Author: Matsuyama, Satoru|Kitajima, Yoshihiko|Sumi, Kenji|Mori, Daisuke|Satoh, Toshimi|Miyazaki, Kohji
PMID: 15010878
Journal: Int J Oncol. 2004 May;24(5):1189-96.
Title: Establishment and characterization of unique human gallbladder cancer cell lines.
Author: Ghosh, Mila|Koike, Naoto|Yanagimoto, Go|Tsunoda, Shin-Ichi|Kaul, Sunil|Hirano, Takashi|Emura, Fabian|Kashiwagi, Hironobu|Kawamoto, Toru|Ohkohchi, Nobuhiro|Saijo, Kaoru|Ohno, Tadao|Miwa, Masanao|Todoroki, Takeshi
PMID: 15067341
Journal: J Gastroenterol Hepatol. 2004 Jul;19(7):812-8.
Title: Immunohistochemical study of microvessel density, CD44 (standard form), p53 protein and c-erbB2 in gallbladder carcinoma.
Author: Kalekou, Harikleia|Miliaras, Dimosthenis
PMID: 15209630
Journal: Int J Oncol. 2005 Feb;26(2):449-56.
Title: Characterization and genetic analysis in the newly established human bile duct cancer cell lines.
Author: Ghosh, Mila|Koike, Naoto|Tsunoda, Shin-Ichi|Hirano, Takashi|Kaul, Sunil|Kashiwagi, Hironobu|Kawamoto, Toru|Ohkohchi, Nobuhiro|Saijo, Kaoru|Ohno, Tadao|Miwa, Masanao|Todoroki, Takeshi
PMID: 15645130
Journal: Korean J Gastroenterol. 2005 Jan;45(1):52-9.
Title: [Expression of epidermal growth factor receptor, ErbB2 and matrix metalloproteinase-9 in hepatolithiasis and cholangiocarcinoma].
Author: Kim, Hyo Jung|Kim, Jae Seon|Kang, Chang Don|Lee, Sung Joon|Kim, Jin Yong|Yeon, Jong Eun|Park, Jong-Jae|Shim, Jae Jeong|Byun, Kwan Soo|Bak, Young-Tae|Lee, Chang Hong
PMID: 15665568
Journal: Biochim Biophys Acta. 2005 Jul 25;1755(2):135-50.
Title: Cyclooxygenase-2 and prostaglandin signaling in cholangiocarcinoma.
Author: Wu, Tong
PMID: 15921858
Journal: Clin Cancer Res. 2005 Aug 1;11(15):5572-80.
Title: Chemopreventive and therapeutic efficacy of orally active tyrosine kinase inhibitors in a transgenic mouse model of gallbladder carcinoma.
Author: Kiguchi, Kaoru|Ruffino, Lynnsie|Kawamoto, Toru|Ajiki, Tetsuo|Digiovanni, John
PMID: 16061875
Journal: J Clin Pathol. 2005 Dec;58(12):1249-54.
Title: FAT, E-cadherin, beta catenin, HER 2/neu, Ki67 immuno-expression, and histological grade in intrahepatic cholangiocarcinoma.
Author: Settakorn, J|Kaewpila, N|Burns, G F|Leong, A S-Y
PMID: 16311342
Journal: Gastroenterology. 2005 Dec;129(6):2047-57.
Title: erbB-2/neu transformed rat cholangiocytes recapitulate key cellular and molecular features of human bile duct cancer.
Author: Lai, Guan-Hua|Zhang, Zichen|Shen, Xue-Ning|Ward, Deanna J|Dewitt, Jennifer L|Holt, Shawn E|Rozich, Rebecca A|Hixson, Douglas C|Sirica, Alphonse E
PMID: 16344070
Journal: Cancer Res Treat. 2005 Jun;37(3):171-6.
Title: Co-expression of cox-2, C-met and beta-catenin in cells forming invasive front of gallbladder cancer.
Author: Moon, Woo Sung|Park, Ho Sung|Lee, Ho|Pai, Rama|Tarnawski, Andrzej S|Kim, Kyung Ryoul|Jang, Kyu Yun
PMID: 19956499
Journal: BMC Cancer. 2006 May 10;6:126.
Title: Preliminary study of p53 and c-erbB-2 expression in gallbladder cancer in Indian patients manuscript id: 8962091628764582.
Author: Chaube, Amita|Tewari, Mallika|Garbyal, R S|Singh, Usha|Shukla, Hari S
PMID: 16686942
Journal: Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4257-64.
Title: MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma.
Author: Tamada, Shugo|Shibahara, Hiroaki|Higashi, Michiyo|Goto, Masamichi|Batra, Surinder K|Imai, Kohzoh|Yonezawa, Suguru
PMID: 16857800
Journal: Ann Oncol. 2007 May;18(5):892-7. Epub 2007 Feb 23.
Title: Gene amplification and protein overexpression of HER-2/neu in human extrahepatic cholangiocarcinoma as detected by chromogenic in situ hybridization and immunohistochemistry: its prognostic implication in node-positive patients.
Author: Kim, H J|Yoo, T W|Park, D I|Park, J H|Cho, Y K|Sohn, C I|Jeon, W K|Kim, B I|Kim, M K|Chae, S W|Sohn, J H
PMID: 17322545
Journal: Cancer Res. 2007 Apr 15;67(8):3794-800.
Title: Therapeutic effect of rapamycin on gallbladder cancer in a transgenic mouse model.
Author: Wu, Qi|Kiguchi, Kaoru|Kawamoto, Toru|Ajiki, Tetsuo|Traag, Jeanine|Carbajal, Steve|Ruffino, Lynnsie|Thames, Howard|Wistuba, Ignacio|Thomas, Melanie|Vasquez, Karen M|DiGiovanni, John
PMID: 17440093
Journal: Anticancer Res. 2007 May-Jun;27(3B):1679-84.
Title: Expression of p21(Wafl/Cip1), p57(Kip2) and HER2/neu in patients with gallbladder cancer.
Author: Puhalla, H|Wrba, F|Kandioler, D|Lehnert, M|Huynh, A|Gruenberger, T|Tamandl, D|Filipits, M
PMID: 17595796
Journal: Hepatobiliary Pancreat Dis Int. 2007 Aug;6(4):412-5.
Title: Expression of c-erbB-2 proto-oncogene in extrahepatic cholangiocarcinoma and its clinical significance.
Author: Zheng, Jun|Zhu, Yao-Ming
PMID: 17690040
Journal: Korean J Gastroenterol. 2007 Dec;50(6):370-8.
Title: [Expressions and clinical significances of c-met, c-erbB-2, COX-2, and IL-6 in the biliary tract cancers].
Author: Joo, Hyun Ho|Song, Eun Young|Jin, Sang Hwa|Oh, Sang Hoon|Choi, Young Kil
PMID: 18159174
Journal: Gastrointest Cancer Res. 2007 Nov;1(6):221-7.
Title: HER Receptor Family: Novel Candidate for Targeted Therapy for Gallbladder and Extrahepatic Bile Duct Cancer.
Author: Kawamoto, Toru|Krishnamurthy, Savitri|Tarco, Emily|Trivedi, Smita|Wistuba, Ignacio I|Li, Donghui|Roa, Ivan|Roa, Juan C|Thomas, Melanie B
PMID: 19262900
Journal: Hepatology. 2008 Apr;47(4):1178-90.
Title: A novel "patient-like" model of cholangiocarcinoma progression based on bile duct inoculation of tumorigenic rat cholangiocyte cell lines.
Author: Sirica, Alphonse E|Zhang, Zichen|Lai, Guan-Hua|Asano, Toru|Shen, Xue-Ning|Ward, Deanna J|Mahatme, Arvind|Dewitt, Jennifer L
PMID: 18081149
Journal: Br J Cancer. 2008 Jan 29;98(2):418-25. Epub 2007 Dec 18.
Title: Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma.
Author: Yoshikawa, D|Ojima, H|Iwasaki, M|Hiraoka, N|Kosuge, T|Kasai, S|Hirohashi, S|Shibata, T
PMID: 18087285
Journal: Eur J Cancer. 2008 May;44(7):1048-56.
Title: MUC4 interacts with ErbB2 in human gallbladder carcinoma: potential pathobiological implications.
Author: Miyahara, Naoki|Shoda, Junichi|Ishige, Kazunori|Kawamoto, Toru|Ueda, Tetsuya|Taki, Ryuuichi|Ohkohchi, Nobuhiro|Hyodo, Ichinosuke|Thomas, Melanie B|Krishnamurthy, Savitri|Carraway, Kermit L|Irimura, Tatsuro
PMID: 18397823
Journal: Int J Med Sci. 2008 Sep 22;5(5):285-91.
Title: EGFR expression in gallbladder carcinoma in North America.
Author: Kaufman, Matthew|Mehrotra, Bhoomi|Limaye, Sewanti|White, Sherrie|Fuchs, Alexander|Lebowicz, Yehuda|Nissel-Horowitz, Sandy|Thomas, Adrienne
PMID: 18825277
Journal: Virchows Arch. 2008 Dec;453(6):579-88.
Title: Immunophenotyping and oncogene amplifications in tumors of the papilla of Vater.
Author: Baumhoer, Daniel|Zlobec, Inti|Tornillo, Luigi|Dietmaier, Wolfgang|Wuensch, Peter H|Hartmann, Arndt|Sessa, Fausto|Ruemmele, Petra|Terracciano, Luigi M
PMID: 18936968
Journal: World J Gastroenterol. 2008 Dec 14;14(46):7033-58.
Title: Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma.
Author: Sirica, Alphonse-E
PMID: 19084911
Journal: Oncology. 2009;76(4):293-300.
Title: A comprehensive analysis of immunohistochemical studies in intrahepatic cholangiocarcinoma using the survival tree model.
Author: Iguchi, Tomohiro|Yamashita, Natsumi|Aishima, Shinichi|Kuroda, Yousuke|Terashi, Takahiro|Sugimachi, Keishi|Taguchi, Ken-ichi|Taketomi, Akinobu|Maehara, Yoshihiko|Tsuneyoshi, Masazumi
PMID: 19262069
Journal: Anticancer Res. 2009 Jan;29(1):19-26.
Title: Gene amplification of Myc and its coamplification with ERBB2 and EGFR in gallbladder adenocarcinoma.
Author: Ooi, Akishi|Suzuki, Shioto|Nakazawa, Kumiko|Itakura, Jun|Imoto, Issei|Nakamura, Hiroyuki|Dobashi, Yoh
PMID: 19331129
Journal: Hepatogastroenterology. 2009 May-Jun;56(91-92):606-9.
Title: Expression of c-erbB-2 and cyclooxygenase-2 in intrahepatic cholangiocarcinoma.
Author: Choi, Hye Jeong|Kim, Hong Jin|Choi, Joon Hyuk
PMID: 19621664
Journal: World J Gastroenterol. 2009 Sep 28;15(36):4511-7.
Title: EGFR and HER2 expression in advanced biliary tract cancer.
Author: Harder, Jan|Waiz, Oliver|Otto, Florian|Geissler, Michael|Olschewski, Manfred|Weinhold, Brigitte|Blum, Hubert E|Schmitt-Graeff, Annette|Opitz, Oliver G
PMID: 19777609
Journal: Hepatobiliary Pancreat Dis Int. 2009 Dec;8(6):620-6.
Title: CA19-9 antigen levels can distinguish between benign and malignant pancreaticobiliary disease.
Author: Morris-Stiff, Gareth|Teli, Mary|Jardine, Nicky|Puntis, Malcolm Ca
PMID: 20007080
Journal: Cancer Sci. 2010 Jan;101(1):54-9.
Title: Identification of transforming activity of free fatty acid receptor 2 by retroviral expression screening.
Author: Hatanaka, Hisashi|Tsukui, Mamiko|Takada, Shuji|Kurashina, Kentaro|Choi, Young Lim|Soda, Manabu|Yamashita, Yoshihiro|Haruta, Hidenori|Hamada, Toru|Ueno, Toshihide|Tamada, Kiichi|Hosoya, Yoshinori|Sata, Naohiro|Yasuda, Yoshikazu|Nagai, Hideo|Sugano, Kentaro
PMID: 19780758
Journal: Hum Pathol. 2010 Apr;41(4):485-92.
Title: Epidermal growth factor receptor and HER-2/neu status by immunohistochemistry and fluorescence in situ hybridization in adenocarcinomas of the biliary tree and gallbladder.
Author: Shafizadeh, Nafis|Grenert, James P|Sahai, Vaibhav|Kakar, Sanjay
PMID: 20040392
Journal: Hepatology. 2010 Sep;52(3):975-86.
Title: Preclinical assessment of simultaneous targeting of epidermal growth factor receptor (ErbB1) and ErbB2 as a strategy for cholangiocarcinoma therapy.
Author: Zhang, Zichen|Oyesanya, Regina A|Campbell, Deanna J W|Almenara, Jorge A|Dewitt, Jennifer L|Sirica, Alphonse E
PMID: 20607690
Journal: Exp Mol Pathol. 2010 Dec;89(3):248-59.
Title: Accumulation of neoplastic traits prior to spontaneous in vitro transformation of rat cholangiocytes determines susceptibility to activated ErbB-2/Neu.
Author: Rozich, Rebecca A|Mills, David R|Brilliant, Kate E|Callanan, Helen M|Yang, DongQin|Tantravahi, Umadevi|Hixson, Douglas C
PMID: 20655306
Journal: World J Gastroenterol. 2010 Aug 28;16(32):4047-54.
Title: High expression of ErbB2 contributes to cholangiocarcinoma cell invasion and proliferation through AKT/p70S6K.
Author: Treekitkarnmongkol, Warapen|Suthiphongchai, Tuangporn
PMID: 20731018
Journal: Exp Mol Pathol. 2010 Dec;89(3):227-35.
Title: Differential gene expression profiling of cultured neu-transformed versus spontaneously-transformed rat cholangiocytes and of corresponding cholangiocarcinomas.
Author: Dumur, Catherine I|Campbell, Deanna J W|DeWitt, Jennifer L|Oyesanya, Regina A|Sirica, Alphonse E
PMID: 20816680
Journal: HPB (Oxford). 2011 May;13(5):309-19.
Title: Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma.
Author: McKay, Siobhan C|Unger, Kristian|Pericleous, Stephanos|Stamp, Gordon|Thomas, Gerry|Hutchins, Robert R|Spalding, Duncan R C
PMID: 21492330
Journal: Gastroenterology. 2012 Apr;142(4):1021-1031.e15.
Title: Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.
Author: Andersen, Jesper B|Spee, Bart|Blechacz, Boris R|Avital, Itzhak|Komuta, Mina|Barbour, Andrew|Conner, Elizabeth A|Gillen, Matthew C|Roskams, Tania|Roberts, Lewis R|Factor, Valentina M|Thorgeirsson, Snorri S
PMID: 22178589
Journal: J Hepatol. 2012 Jul;57(1):84-91.
Title: The therapeutic effect of histone deacetylase inhibitor PCI-24781 on gallbladder carcinoma in BK5.erbB2 mice.
Author: Kitamura, Takuya|Connolly, Kevin|Ruffino, Lynnsie|Ajiki, Tetsuo|Lueckgen, Aline|DiGiovanni, John|Kiguchi, Kaoru
PMID: 22326466
Journal: World J Gastroenterol. 2012 Mar 21;18(11):1208-15.
Title: Expression of HER2 and bradykinin B(1) receptors in precursor lesions of gallbladder carcinoma.
Author: Toledo, Cesar|Matus, Carola E|Barraza, Ximena|Arroyo, Pamela|Ehrenfeld, Pamela|Figueroa, Carlos D|Bhoola, Kanti D|Del Pozo, Maeva|Poblete, Maria T
PMID: 22468084
Journal: Indian J Pathol Microbiol. 2012 Jan-Mar;55(1):75-9.
Title: Role of C-erbB2 expression in gallbladder cancer.
Author: Kumari, Niraj|Kapoor, V K|Krishnani, Narendra|Kumar, Kamlesh|Baitha, Dinesh Kumar
PMID: 22499306
Journal: Virchows Arch. 2012 Nov;461(5):521-30.
Title: HER3 overexpression is a prognostic indicator of extrahepatic cholangiocarcinoma.
Author: Lee, Hee Jin|Chung, Joon-Yong|Hewitt, Stephen M|Yu, Eunsil|Hong, Seung-Mo
PMID: 23052372
Journal: Oncotarget. 2013 Jan;4(1):156-65.
Title: Targeted therapy of advanced gallbladder cancer and cholangiocarcinoma with aggressive biology: eliciting early response signals from phase 1 trials.
Author: Subbiah, Ishwaria M|Subbiah, Vivek|Tsimberidou, Apostolia M|Naing, Aung|Kaseb, Ahmed O|Javle, Milind|Fu, Siqing|Hong, David S|Piha-Paul, Sarina|Wheler, Jennifer J|Hess, Kenneth R|Janku, Filip|Falchook, Gerald S|Wolff, Robert A|Kurzrock, Razelle
PMID: 23391555
Journal: Korean J Intern Med. 2013 Sep;28(5):573-8.
Title: Expression of procaspase 3 and activated caspase 3 and its relevance in hormone-responsive gallbladder carcinoma chemotherapy.
Author: Maurya, Sanjeev Kumar|Tewari, Mallika|Sharma, Bechan|Shukla, Hari Shanker
PMID: 24009453
Journal: Mod Pathol. 2014 Jan;27(1):73-86.
Title: Intraductal papillary neoplasms of the bile duct: stepwise progression to carcinoma involves common molecular pathways.
Author: Schlitter, Anna Melissa|Born, Diana|Bettstetter, Marcus|Specht, Katja|Kim-Fuchs, Corina|Riener, Marc-Oliver|Jeliazkova, Petia|Sipos, Bence|Siveke, Jens T|Terris, Benoit|Zen, Yoh|Schuster, Tibor|Hofler, Heinz|Perren, Aurel|Kloppel, Gunter|Esposito, Irene
PMID: 23828315
Journal: Mol Cancer Res. 2014 Jan;12(1):91-100.
Title: Cocarcinogenic effects of intrahepatic bile acid accumulation in cholangiocarcinoma development.
Author: Lozano, Elisa|Sanchez-Vicente, Laura|Monte, Maria J|Herraez, Elisa|Briz, Oscar|Banales, Jesus M|Marin, Jose J G|Macias, Rocio I R
PMID: 24255171
Journal: J Hepatobiliary Pancreat Sci. 2014 Jun;21(6):371-9.
Title: Molecular aspects of cholangiocarcinoma.
Author: Kiguchi, Kaoru
PMID: 24420749
Journal: J Hepatobiliary Pancreat Sci. 2014 Jun;21(6):380-7.
Title: Genomic and transcriptional alterations of cholangiocarcinoma.
Author: Ito, Takeshi|Sakurai-Yageta, Mika|Goto, Akiteru|Pairojkul, Chawalit|Yongvanit, Puangrat|Murakami, Yoshinori
PMID: 24532422
Journal: J Gastroenterol Hepatol. 2014 Aug;29(8):1582-94.
Title: Differences in immunohistochemical biomarkers between intra- and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis.
Author: Wiggers, Jimme K|Ruys, Anthony T|Groot Koerkamp, Bas|Beuers, Ulrich|ten Kate, Fiebo J|van Gulik, Thomas M
PMID: 24787096
Journal: Gastrointest Cancer Res. 2014 Mar;7(2):42-8.
Title: Overexpression of the HER2/neu Gene: A New Therapeutic Possibility for Patients With Advanced Gallbladder Cancer.
Author: Roa, Ivan|de Toro, Gonzalo|Schalper, Kurt|de Aretxabala, Xabier|Churi, Chaitanya|Javle, Milind
PMID: 24799970
Journal: Hum Pathol. 2014 Aug;45(8):1630-8.
Title: Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma.
Author: Graham, Rondell P|Barr Fritcher, Emily G|Pestova, Ekaterina|Schulz, John|Sitailo, Leonid A|Vasmatzis, George|Murphy, Stephen J|McWilliams, Robert R|Hart, Steven N|Halling, Kevin C|Roberts, Lewis R|Gores, Gregory J|Couch, Fergus J|Zhang, Lizhi|Borad, Mites
PMID: 24837095
Journal: Am Soc Clin Oncol Educ Book. 2014:e165-70.
Title: A review of recent data in the treatment of gallbladder cancer: what we know, what we do, and what should be done.
Author: Muller, Bettina G|De Aretxabala, Xabier|Gonzalez Domingo, Manuel
PMID: 24857099
Journal: Oncol Rep. 2014 Aug;32(2):700-8.
Title: Characterization of EGFR family gene aberrations in cholangiocarcinoma.
Author: Yang, Xiaoqing|Wang, Weishan|Wang, Chunni|Wang, Lin|Yang, Muyi|Qi, Mei|Su, Hong|Sun, Xiubin|Liu, Zhiyan|Zhang, Juan|Qin, Xiaomin|Han, Bo
PMID: 24927194
Journal: Nat Genet. 2014 Aug;46(8):872-6.
Title: Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway.
Author: Li, Maolan|Zhang, Zhou|Li, Xiaoguang|Ye, Junyi|Wu, Xiangsong|Tan, Zhujun|Liu, Chang|Shen, Baiyong|Wang, Xu-An|Wu, Wenguang|Zhou, Daizhan|Zhang, Di|Wang, Ting|Liu, Bingya|Qu, Kai|Ding, Qichen|Weng, Hao|Ding, Qian|Mu, Jiasheng|Shu, Yijun|Bao, Runfa|Cao, Yan
PMID: 24997986
Journal: Oncol Rep. 2014 Nov;32(5):1796-802.
Title: Interaction of Muc4 and ErbB2 in a transgenic mouse model of gallbladder carcinoma: potential pathobiological implications.
Author: Miyahara, Naoki|Shoda, Junichi|Kawamoto, Toru|Ishida, Hiroyasu|Ueda, Tetsuya|Akimoto, Yoshihiro|Kawakami, Hayato|Irimura, Tatsuro
PMID: 25174601
Journal: Biochem Biophys Res Commun. 2014 Sep 26;452(3):614-21.
Title: SOX4 is associated with poor prognosis in cholangiocarcinoma.
Author: Wang, Weishan|Zhang, Jing|Zhan, Xuemei|Lin, Tao|Yang, Muyi|Hu, Jing|Han, Bo|Hu, Sanyuan
PMID: 25181339
Journal: PLoS One. 2014 Dec 23;9(12):e115383.
Title: Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications.
Author: Churi, Chaitanya R|Shroff, Rachna|Wang, Ying|Rashid, Asif|Kang, HyunSeon C|Weatherly, Jacqueline|Zuo, Mingxin|Zinner, Ralph|Hong, David|Meric-Bernstam, Funda|Janku, Filip|Crane, Christopher H|Mishra, Lopa|Vauthey, Jean-Nicholas|Wolff, Robert A|Mills, Gord
PMID: 25536104
Journal: Mol Carcinog. 2015 Jun;54(6):459-72.
Title: Bile acid accelerates erbB2-induced pro-tumorigenic activities in biliary tract cancer.
Author: Kitamura, Takuya|Srivastava, Jaya|DiGiovanni, John|Kiguchi, Kaoru
PMID: 24839254
Journal: Pathol Oncol Res. 2015 Jul;21(3):831-8.
Title: Prognostic value of increased HER2 expression in cancers of pancreas and biliary tree.
Author: Ata, Alper|Polat, Ayse|Serinsoz, Ebru|Sungur, Mehmet Ali|Arican, Ali
PMID: 25416598
Journal: Virchows Arch. 2015 Apr;466(4):393-402.
Title: Microsatellite instability in gallbladder carcinoma.
Author: Moy, Andrea P|Shahid, Mohammad|Ferrone, Cristina R|Borger, Darrell R|Zhu, Andrew X|Ting, David|Deshpande, Vikram
PMID: 25680569
Journal: Cancer Metastasis Rev. 2015 Mar;34(1):157-64.
Title: HER2 expression status in diverse cancers: review of results from 37,992 patients.
Author: Yan, Min|Schwaederle, Maria|Arguello, David|Millis, Sherri Z|Gatalica, Zoran|Kurzrock, Razelle
PMID: 25712293
Journal: J Hepatol. 2015 Aug;63(2):399-407.
Title: Breast tumor kinase/protein tyrosine kinase 6 (Brk/PTK6) activity in normal and neoplastic biliary epithelia.
Author: Mizuguchi, Yoshiaki|Specht, Susan|Isse, Kumiko|Sasatomi, Eizaburo|Lunz, John G 3rd|Takizawa, Toshihiro|Demetris, Anthony J
PMID: 25770659
Journal: Mod Pathol. 2015 Aug;28(8):1123-9.
Title: Sequencing of 279 cancer genes in ampullary carcinoma reveals trends relating to histologic subtypes and frequent amplification and overexpression of ERBB2 (HER2).
Author: Hechtman, Jaclyn F|Liu, Weiguo|Sadowska, Justyna|Zhen, Lisa|Borsu, Laetitia|Arcila, Maria E|Won, Helen H|Shah, Ronak H|Berger, Michael F|Vakiani, Efsevia|Shia, Jinru|Klimstra, David S
PMID: 25975284
Journal: J Hematol Oncol. 2015 May 29;8:58.
Title: HER2/neu-directed therapy for biliary tract cancer.
Author: Javle, Milind|Churi, Chaitanya|Kang, HyunSeon C|Shroff, Rachna|Janku, Filip|Surapaneni, Rakesh|Zuo, Mingxin|Barrera, Christian|Alshamsi, Humaid|Krishnan, Sunil|Mishra, Lopa|Wolff, Robert A|Kaseb, Ahmed O|Thomas, Melanie B|Siegel, Abby B
PMID: 26022204
Journal: Mod Pathol. 2015 Sep;28(9):1249-64.
Title: Intraductal tubulopapillary neoplasms of the bile ducts: clinicopathologic, immunohistochemical, and molecular analysis of 20 cases.
Author: Schlitter, Anna Melissa|Jang, Kee-Taek|Kloppel, Gunter|Saka, Burcu|Hong, Seung-Mo|Choi, Hyejeong|Offerhaus, George Johan|Hruban, Ralph H|Zen, Yoh|Konukiewitz, Bjorn|Regel, Ivonne|Allgauer, Michael|Balci, Serdar|Basturk, Olca|Reid, Michelle D|Esposito, Ire
PMID: 26111977
Journal: PLoS One. 2015 Nov 16;10(11):e0142124.
Title: Sensitivity of Human Intrahepatic Cholangiocarcinoma Subtypes to Chemotherapeutics and Molecular Targeted Agents: A Study on Primary Cell Cultures.
Author: Fraveto, Alice|Cardinale, Vincenzo|Bragazzi, Maria Consiglia|Giuliante, Felice|De Rose, Agostino Maria|Grazi, Gian Luca|Napoletano, Chiara|Semeraro, Rossella|Lustri, Anna Maria|Costantini, Daniele|Nevi, Lorenzo|Di Matteo, Sabina|Renzi, Anastasia|Carpino,
PMID: 26571380
Journal: Tumour Biol. 2016 Mar;37(3):4041-52.
Title: Establishment and characterization of a human intrahepatic cholangiocarcinoma cell line derived from an Italian patient.
Author: Cavalloni, Giuliana|Peraldo-Neia, Caterina|Varamo, Chiara|Casorzo, Laura|Dell'Aglio, Carmine|Bernabei, Paola|Chiorino, Giovanna|Aglietta, Massimo|Leone, Francesco
PMID: 26486326
Journal: J Clin Pathol. 2016 May;69(5):403-8.
Title: Comprehensive genomic profiling of extrahepatic cholangiocarcinoma reveals a long tail of therapeutic targets.
Author: Lee, Hwajeong|Wang, Kai|Johnson, Adrienne|Jones, David M|Ali, Siraj M|Elvin, Julia A|Yelensky, Roman|Lipson, Doron|Miller, Vincent A|Stephens, Philip J|Javle, Milind|Ross, Jeffrey S
PMID: 26500333
Journal: Expert Opin Biol Ther. 2016;16(2):243-53.
Title: Pertuzumab in gastrointestinal cancer.
Author: Oh, Do-Youn|Bang, Yung-Jue
PMID: 26619359
Journal: Virchows Arch. 2016 Apr;468(4):431-9.
Title: A significant subgroup of resectable gallbladder cancer patients has an HER2 positive status.
Author: Yoshida, Hiroshi|Shimada, Kazuaki|Kosuge, Tomoo|Hiraoka, Nobuyoshi
PMID: 26758058
Journal: Cancer Metastasis Rev. 2016 Jun;35(2):263-75.
Title: Genomics of gallbladder cancer: the case for biomarker-driven clinical trial design.
Author: Sicklick, Jason K|Fanta, Paul T|Shimabukuro, Kelly|Kurzrock, Razelle
PMID: 26857926
Journal: Gulf J Oncolog. 2016 Jan;1(20):12-9.
Title: EGFR and HER-2/neu Expression in Gallbladder Carcinoma: An Institutional Experience.
Author: Hadi, R|Pant, M C|Husain, N|Singhal, A|Khurana, R|Agarwal, G R|Masood, S|Awashthi, N P
PMID: 27050174
Journal: Z Gastroenterol. 2016 May;54(5):426-30.
Title: [Durable remission under dual HER2 blockade with Trastuzumab and Pertuzumab in a patient with metastatic gallbladder cancer].
Author: Czink, E|Heining, C|Weber, T F|Lasitschka, F|Schemmer, P|Schirmacher, P|Weiss, K H|Glimm, H|Brors, B|Weichert, W|Jager, D|Frohling, S|Springfeld, C
PMID: 27171333
Journal: Transl Oncol. 2016 Jun;9(3):173-8.
Title: Genomic Alterations in Biliary Tract Cancer Using Targeted Sequencing.
Author: Yoo, Kwai Han|Kim, Nayoung K D|Kwon, Woo Il|Lee, Chung|Kim, Sun Young|Jang, Jiryeon|Ahn, Jungmi|Kang, Mihyun|Jang, Hyojin|Kim, Seung Tae|Ahn, Soomin|Jang, Kee-Taek|Park, Young Suk|Park, Woong-Yang|Lee, Jeeyun|Heo, Jin Seok|Park, Joon Oh
PMID: 27267833
Journal: Oncotarget. 2016 Sep 6;7(36):58007-58021.
Title: Therapeutic implication of HER2 in advanced biliary tract cancer.
Author: Nam, Ah-Rong|Kim, Ji-Won|Cha, Yongjun|Ha, Hyerim|Park, Ji Eun|Bang, Ju-Hee|Jin, Mei Hua|Lee, Kyung-Hun|Kim, Tae-Yong|Han, Sae-Won|Im, Seock-Ah|Kim, Tae-You|Oh, Do-Youn|Bang, Yung-Jue
PMID: 27517322
Journal: Cancer. 2016 Dec 15;122(24):3838-3847.
Title: Biliary cancer: Utility of next-generation sequencing for clinical management.
Author: Javle, Milind|Bekaii-Saab, Tanios|Jain, Apurva|Wang, Ying|Kelley, Robin Katie|Wang, Kai|Kang, Hyunseon C|Catenacci, Daniel|Ali, Siraj|Krishnan, Sunil|Ahn, Daniel|Bocobo, Andrea Grace|Zuo, Mingxin|Kaseb, Ahmed|Miller, Vincent|Stephens, Philip J|Meric-Berns
PMID: 27622582
Journal: Asian Pac J Cancer Prev. 2016;17(8):3903-9.
Title: Expression of Human Epidermal Growth Factor Receptor (Her 2/neu) and Proliferative Marker Ki-67: Association with Clinicopathological Parameters in Gallbladder Carcinoma.
Author: Pujani, Mukta|Makker, Isha|Makker, Annu|Jetley, Sujata|Goel, Madhu Mati|Jetley, Sujata
PMID: 27644637
Journal: J Gastrointest Oncol. 2016 Oct;7(5):797-803.
Title: Molecular profiling of biliary tract cancer: a target rich disease.
Author: Jain, Apurva|Javle, Milind
PMID: 27747093
Journal: Cancer Metastasis Rev. 2017 Mar;36(1):141-157.
Title: HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?
Author: Galdy, Salvatore|Lamarca, Angela|McNamara, Mairead G|Hubner, Richard A|Cella, Chiara A|Fazio, Nicola|Valle, Juan W
PMID: 27981460
Journal: Mol Cancer Ther. 2017 Jun;16(6):1145-1154.
Title: Resistance Mechanism against Trastuzumab in HER2-Positive Cancer Cells and Its Negation by Src Inhibition.
Author: Jin, Mei Hua|Nam, Ah-Rong|Park, Ji Eun|Bang, Ju-Hee|Bang, Yung-Jue|Oh, Do-Youn
PMID: 28223426
Journal: Pathol Res Pract. 2017 May;213(5):476-482.
Title: The ERK/MAPK pathway is overexpressed and activated in gallbladder cancer.
Author: Buchegger, Kurt|Silva, Ramon|Lopez, Jaime|Ili, Carmen|Araya, Juan Carlos|Leal, Pamela|Brebi, Priscilla|Riquelme, Ismael|Roa, Juan Carlos
PMID: 28285962
Journal: Zhonghua Bing Li Xue Za Zhi. 2017 Apr 8;46(4):245-248.
Title: [Clinical significance of HER2 positivity in gallbladder adenocarcinoma].
Author: Yao, J G|Wang, C H|Liu, Y
PMID: 28376590
Journal: Mol Carcinog. 2017 Sep;56(9):2146-2157.
Title: High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapy.
Author: Quintavalle, Cristina|Burmeister, Katharina|Piscuoglio, Salvatore|Quagliata, Luca|Karamitopoulou, Eva|Sepe, Romina|Fusco, Alfredo|Terracciano, Luigi M|Andersen, Jesper B|Pallante, Pierlorenzo|Matter, Matthias S
PMID: 28467612
Journal: Therap Adv Gastroenterol. 2017 Jun;10(6):507-520.
Title: The potential role of comprehensive genomic profiling to guide targeted therapy for patients with biliary cancer.
Author: Lee, Hwajeong|Ross, Jeffrey S
PMID: 28567120
Journal: Hepatology. 2017 Jul 3.
Title: Role of ErbB/HER family of receptor tyrosine kinases in cholangiocyte biology.
Author: Pellat, Anna|Vaquero, Javier|Fouassier, Laura
PMID: 28671339
Journal: J Gastrointest Oncol. 2017 Jun;8(3):430-440.
Title: Current biologics for treatment of biliary tract cancers.
Author: Zhao, Diana Y|Lim, Kian-Huat
PMID: 28736630
Journal: Pathology. 2017 Oct;49(6):582-588.
Title: Gene copy number variation and protein overexpression of EGFR and HER2 in distal extrahepatic cholangiocarcinoma.
Author: Jung, Min Jung|Woo, Chang Gok|Lee, Saetbyeol|Chin, Susie|Kim, Hee Kyung|Kwak, Jeong Ja|Koh, Eun Suk|Lee, Bora|Jang, Kee-Taek|Moon, Ahrim
PMID: 28843919
Journal: Am J Cancer Res. 2018 Jan 1;8(1):2-15. eCollection 2018.
Title: Genotyping and mRNA profiling reveal actionable molecular targets in biliary tract cancers.
Author: Papadopoulou, Kyriaki|Murray, Samuel|Manousou, Kyriaki|Tikas, Ioannis|Dervenis, Christos|Sgouros, Joseph|Rontogianni, Dimitra|Lakis, Sotirios|Bobos, Mattheos|Poulios, Christos|Pervana, Stavroula|Lazaridis, Georgios|Fountzilas, George|Kotoula, Vassiliki
PMID: 29416916
Journal: Future Oncol. 2018 Mar;14(6):553-566.
Title: Novel targeted therapy strategies for biliary tract cancers and hepatocellular carcinoma.
Author: DeLeon, Thomas T|Ahn, Daniel H|Bogenberger, James M|Anastasiadis, Panos Z|Arora, Mansi|Ramanathan, Ramesh K|Aqel, Bashar A|Vasmatzis, George|Truty, Mark J|Oklu, Rahmi|Bekaii-Saab, Tanios S|Borad, Mitesh J
PMID: 29460642
Journal: Pathol Res Pract. 2018 Jun;214(6):835-839.
Title: MiR-21 up-regulation in ampullary adenocarcinoma and its pre-invasive lesions.
Author: Saraggi, Deborah|Galuppini, Francesca|Fanelli, Giuseppe N|Remo, Andrea|Urso, Emanuele D L|Bao, Ricardo Q|Bacchin, Deborah|Guzzardo, Vincenza|Luchini, Claudio|Braconi, Chiara|Farinati, Fabio|Rugge, Massimo|Fassan, Matteo
PMID: 29731265
Journal: Clin Cancer Res. 2018 Sep 1;24(17):4154-4161.
Title: Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention.
Author: Lowery, Maeve A|Ptashkin, Ryan|Jordan, Emmet|Berger, Michael F|Zehir, Ahmet|Capanu, Marinela|Kemeny, Nancy E|O'Reilly, Eileen M|El-Dika, Imane|Jarnagin, William R|Harding, James J|D'Angelica, Michael I|Cercek, Andrea|Hechtman, Jaclyn F|Solit, David B|Schu
PMID: 29848569
Journal: Jpn J Clin Oncol. 2018 Aug 1;48(8):703-711.
Title: New developments in systemic therapy for advanced biliary tract cancer.
Author: Morizane, Chigusa|Ueno, Makoto|Ikeda, Masafumi|Okusaka, Takuji|Ishii, Hiroshi|Furuse, Junji
PMID: 29893894
Journal: BMC Cancer. 2018 Jun 18;18(1):665.
Title: Gallbladder cancer: review of a rare orphan gastrointestinal cancer with a focus on populations of New Mexico.
Author: Nemunaitis, Jacklyn M|Brown-Glabeman, Ursa|Soares, Heloisa|Belmonte, Jessica|Liem, Ben|Nir, Itzhak|Phuoc, Victor|Gullapalli, Rama R
PMID: 29914418
Journal: Gut. 2018 Jun 28. pii: gutjnl-2018-316039.
Title: Genomic ERBB2/ERBB3 mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysis.
Author: Li, Maolan|Liu, Fatao|Zhang, Fei|Zhou, Weiping|Jiang, Xiaoqing|Yang, Yuan|Qu, Kai|Wang, Yueqi|Ma, Qiang|Wang, Ting|Bai, Lu|Wang, Zheng|Song, Xiaoling|Zhu, Yidi|Yuan, Ruiyan|Gao, Yuan|Liu, Yongchen|Jin, Yunpeng|Li, Huaifeng|Xiang, Shanshan|Ye, Yuanyuan|Zha
PMID: 29954840
Journal: J Gastrointest Cancer. 2018 Aug 29. pii: 10.1007/s12029-018-0162-8.
Title: Significance of HER2 and Ki-67 in Preneoplastic Lesions and Carcinoma of Gallbladder.
Author: Halder, Sutapa|Kundu, Sayan|Chakraborty, Jayati|Chakrabarti, Sudipta
PMID: 30155833
Journal: Int J Cancer. 2018 Oct 10.
Title: ERBB2 and KRAS Alterations Mediate Response to EGFR Inhibitors in Early Stage Gallbladder Cancer.
Author: Iyer, Prajish|Shrikhande, Shailesh V|Ranjan, Malika|Joshi, Asim|Gardi, Nilesh|Prasad, Ratnam|Dharavath, Bhasker|Thorat, Rahul|Salunkhe, Sameer|Sahoo, Bikram|Chandrani, Pratik|Kore, Hitesh|Mohanty, Bhabani|Chaudhari, Vikram|Choughule, Anuradha|Kawle, Dhana
PMID: 30304546
Journal: PLoS One. 2018 Oct 18;13(10):e0206007.
Title: The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers.
Author: Lamarca, Angela|Galdy, Salvatore|Barriuso, Jorge|Moghadam, Sharzad|Beckett, Elizabeth|Rogan, Jane|Backen, Alison|Billington, Catherine|McNamara, Mairead G|Hubner, Richard A|Cramer, Angela|Valle, Juan W
PMID: 30335866